title: Thromboxane-induced contractile response of human coronary arterioles is diminished after cardioplegic arrest.
abstract: BACKGROUND
  We investigated the contractile response of human coronary microvasculature to thromboxane A-2 (TXA-2), with and without the blockade of TXA-2 receptors or the inhibition of phospholipase-C (PLC) or of protein kinase C-α (PKC-α) in the human coronary microvasculature before and after cardioplegia, followed by reperfusion (CP/Rep). Protein/gene expression and localization of TXA-2 receptors, TXA-2 synthase, PLC, and other TXA-2-related proteins was also examined.
  
  
  METHODS
  Right atrial tissue was harvested before and after cold blood cardioplegia, followed by about 10 minutes of reperfusion, from 28 patients undergoing cardiac operations. Coronary arterioles (90 to 170 μm in diameter) were dissected from the harvested tissue.
  
  
  RESULTS
  The post-CP/Rep contractile response of coronary arterioles to TXA-2 analog U-46619 was significantly impaired vs pre-CP/Rep (p<0.05). The TXA-2 receptor antagonist SQ-29548 (10(-6) M) prevented the contractile response to U-46619 (p<0.05). Pretreatment with the PLC inhibitor U73122 (10(-6) M) significantly inhibited the U-46619-induced contractile response (p<0.05). Administration of the PKC-α inhibitor safingol failed to affect U-46619-induced contraction. Total protein levels and gene expression of TXA-2 receptors, TXA-2 synthase, PLC-β3, phospho-PLC-β3, PLC-γ1, and phospho-PLC-γ1 were not altered after CP/Rep. Confocal microscopy showed no significant differences in the expression of TXA-2 receptors or PLC-β3 in the microcirculation. TXA-2 receptors and PLC-β3 were both present in smooth muscle and endothelium.
  
  
  CONCLUSIONS
  Cardioplegia/Rep decreases the contractile response of human coronary arterioles to TXA-2 soon after cardiac operations. The contractile response to the TXA-2 analog U-46619 is through activation of TXA-2 receptors and PLC.
authors.affiliation: Division of Cardiothoracic Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island 02903, USA.
authors.forename: Jun
authors.initials: J
authors.lastname: Feng
authors.forename: Yuhong
authors.initials: Y
authors.lastname: Liu
authors.forename: Louis M
authors.initials: LM
authors.lastname: Chu
authors.forename: Richard T
authors.initials: RT
authors.lastname: Clements
authors.forename: Kamal R
authors.initials: KR
authors.lastname: Khabbaz
authors.forename: Michael P
authors.initials: MP
authors.lastname: Robich
authors.forename: Cesario
authors.initials: C
authors.lastname: Bianchi
authors.forename: Frank W
authors.initials: FW
authors.lastname: Sellke
mesh_terms: D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / Q000494:pharmacology; D000368:Aged; D001160:Arterioles / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D003326:Coronary Circulation / Q000187:drug effects / Q000502:physiology*; D003327:Coronary Disease / Q000503:physiopathology / Q000601:surgery*; D003331:Coronary Vessels / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D006324:Heart Arrest, Induced / Q000009:adverse effects*; D006801:Humans; D015151:Immunoblotting; D008297:Male; D046228:Microarray Analysis; D018613:Microscopy, Confocal; D012313:RNA / Q000235:genetics; D044244:Receptors, Thromboxane A2, Prostaglandin H2 / Q000096:biosynthesis / Q000235:genetics; D013928:Thromboxane A2 / Q000494:pharmacology*; D013930:Thromboxane-A Synthase / Q000096:biosynthesis / Q000235:genetics; D010738:Type C Phospholipases / Q000096:biosynthesis / Q000235:genetics; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*
chemical_list: D044244:Receptors, Thromboxane A2, Prostaglandin H2; D013928:Thromboxane A2; D012313:RNA; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D010738:Type C Phospholipases; D013930:Thromboxane-A Synthase